These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Regulation of cAMP Intracellular Levels in Human Platelets Stimulated by 2-Arachidonoylglycerol. Signorello MG; Leoncini G J Cell Biochem; 2016 May; 117(5):1240-9. PubMed ID: 26460717 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of nicotinic responses of bovine adrenal chromaffin cells by the protein kinase C inhibitor, Ro 31-8220. Marley PD; Thomson KA Br J Pharmacol; 1996 Sep; 119(2):416-22. PubMed ID: 8886429 [TBL] [Abstract][Full Text] [Related]
12. NPY1-36 and PYY1-36 activate cardiac fibroblasts: an effect enhanced by genetic hypertension and inhibition of dipeptidyl peptidase 4. Zhu X; Gillespie DG; Jackson EK Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1528-42. PubMed ID: 26371160 [TBL] [Abstract][Full Text] [Related]
13. Human syncytiotrophoblast NPY receptors are located on BBM and activate PLC-to-PKC axis. Robidoux J; Simoneau L; St-Pierre S; Ech-Chadli H; Lafond J Am J Physiol; 1998 Mar; 274(3):E502-9. PubMed ID: 9530134 [TBL] [Abstract][Full Text] [Related]
14. Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells. Rosmaninho-Salgado J; Araújo IM; Alvaro AR; Duarte EP; Cavadas C J Neurochem; 2007 Nov; 103(3):896-903. PubMed ID: 17868303 [TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y inhibits chromaffin cell nicotinic receptor-stimulated tyrosine hydroxylase activity through a receptor-linked G protein-mediated process. Zheng J; Zhang P; Hexum TD Mol Pharmacol; 1997 Dec; 52(6):1027-33. PubMed ID: 9415712 [TBL] [Abstract][Full Text] [Related]
16. A novel phospholipase C- and cAMP-independent positive inotropic mechanism via a P2 purinoceptor. Podrasky E; Xu D; Liang BT Am J Physiol; 1997 Nov; 273(5):H2380-7. PubMed ID: 9374775 [TBL] [Abstract][Full Text] [Related]
17. Characterization of G protein and phospholipase C-coupled agonist binding to the Y1 neuropeptide Y receptor in rat brain: sensitivity to G protein activators and inhibitors and to inhibitors of phospholipase C. Parker SL; Parker MS; Sweatman T; Crowley WR J Pharmacol Exp Ther; 1998 Jul; 286(1):382-91. PubMed ID: 9655883 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A system. Nörenberg W; Bek M; Limberger N; Takeda K; Illes P Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):337-47. PubMed ID: 7543184 [TBL] [Abstract][Full Text] [Related]
19. The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte. Piper HM; Millar BC; McDermott BJ Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):333-7. PubMed ID: 2554154 [TBL] [Abstract][Full Text] [Related]
20. The antiadrenergic effect of neuropeptide Y on the ventricular cardiomyocyte. Millar BC; Piper HM; McDermott BJ Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):426-9. PubMed ID: 2854210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]